Gonococcal infections continue to be a global public health concern, with an estimated 87 million new cases reported annually worldwide. The burden of gonorrhea is disproportionately high among young adults, with the highest incidence rates observed in individuals aged 15 to 24. Factors such as inconsistent condom use, multiple sexual partners, and inadequate access to healthcare contribute to the persistence of gonococcal infections. Efforts to control the spread of gonorrhea involve a combination of prevention, diagnosis, and treatment strategies. Public health initiatives emphasize education on safe sex practices, the promotion of condom use, and routine screening for sexually active individuals, especially those at higher risk. Partner notification and treatment are crucial components of comprehensive gonococcal infection control programs. Research into the development of a gonorrhea vaccine is underway, aiming to provide long-term protection against Neisseria gonorrhoeae. Additionally, ongoing surveillance is essential to monitor trends in antibiotic resistance and guide treatment recommendations. The collaboration between healthcare providers, researchers, and public health agencies is vital for developing effective strategies to curb the global burden of gonococcal infections and address the challenges posed by antibiotic resistance.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain